Hooshmand Sheshbaradaran, PhD

Head Global Development Strategy, Business Development & Marketing Advisory Group

Novateur Advisor Since

2015

Field

Business Development

Specialties

Oncology Licensing, Immunology Licensing, M&A

Dr. Hooshmand Sheshbaradaran advises Novateur clients on global business development and market positioning of oncology and infectious disease products. He has over 20 years of experience in the pharmaceutical and biotechnology sectors, in drug development, marketing, business development, financing, and executive operations. Previously, Dr. Sheshbaradaran has held senior global marketing and business development executive positions in several leading pharmaceutical companies, including Global Director of Oncology Business Development at Roche and Global Director of Oncology, New Products Marketing at Pharmacia/Pfizer. He also has extensive small biotech experience, including holding positions such as Chief Business Officer at PsiOxus Therapeutics Ltd, Head of the US subsidiary of Zeneus Pharma Ltd. (acquired by Cephalon, Inc. in 2007), and co-founder and CEO of Niiki Pharma Inc (acquired by Intezyne Technologies in 2013). Dr. Sheshbaradaran has been involved in the development of several anti-cancer drugs, including Camptosar, Ellence, Emcyt, Sutent, and Vidaza. During his business career in the pharmaceutical industry, he has participated and closed on M&As, global licensing deals, and numerous regional and university deals.

Novateur
Newsletter

Subscribe to our newsletter for access to latest updates.

Resource
Databases

Access Novateur news as well as FDA and Expert Databases.

Relevant
Events

Check out conferences and events we are attending!

Article
Features

Read articles by our team! Featured in BioteCanada Insights and Nature among others.